市場調査レポート

商品コード

1520620

マルチプレックスアッセイの世界市場の評価：製品別、タイプ別、技術別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Multiplex Assays Market Assessment, By Product, By Type, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年07月25日
発行: Market Xcel - Markets and Data
ページ情報: 英文 231 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 658,440円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 834,024円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,199,824円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.32円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のマルチプレックスアッセイの市場規模は、予測期間の2024年～2031年のCAGRが10.16％に達し、2023年の31億9,000万米ドルから2031年には69億2,000万米ドルに成長すると予測されています。市場の拡大は、自己免疫疾患、慢性疾患、感染症の有病率の増加、医薬品開発・発見に向けた投資の増加、マルチプレックスアッセイの応用拡大によって後押しされています。自己抗体の検出は、がん、自己免疫疾患、サイトカイン、感染症研究において不可欠であり、マルチプレックス分析は、研究者が1つのサンプルから複数の自己抗体を測定することを助け、時間効率を向上させる。そのため、臨床およびライフサイエンス・アプリケーションのためのマルチプレックスアッセイへの要求が高まっています。

世界中の様々な地域でがん患者が増加していることが、世界のマルチプレックスアッセイ市場の需要を促進しています。米国国立がん研究所の推計によると、2024年には米国で新たに2,001,140人のがん患者が診断される見込みです。Luminexの技術を用いた循環がんバイオマーカー・ビーズ・ベースのマルチプレックスアッセイは、複数の種類の腫瘍における複数のがんバイオマーカーの同時分析を可能にします。また、免疫腫瘍学、肺がん、乳がん研究の進展にも役立っています。非腫瘍と腫瘍を区別するためには、単離されたタンパク質バイオマーカーを検出するだけでは十分でないことが多いとみられています。マルチプレックスアッセイの助けを借りて循環がんマーカーと細胞内がんマーカーを多重検出することで、腫瘍形成プロセスと正常な恒常性に関連する研究を加速させることができます。

医薬品開発と創薬への重点が高まっていることは、マルチプレックスアッセイの世界市場規模を押し上げる主な要因の1つです。創薬は、製薬部門が病気の治療に役立つ分子実体を決定するのに役立ちます。医薬品開発プロセスに関連する様々なステップは、安全性、有効性、医薬品に関連する様々なリスクの評価に役立ちます。そのため、さまざまな企業が、医薬品開発や創薬に不可欠なさまざまなステップの速度を向上させることができるソリューションの開発に積極的に投資しています。

当レポートでは、世界のマルチプレックスアッセイ市場について調査し、市場の概要とともに、製品別、タイプ別、技術別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 3. Global Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 4. Global Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 5. Global Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 6. Global Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 7. Global Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 8. Global Multiplex Assays Market Share (%), By Region, 2017-2031F
Figure 9. North America Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 10. North America Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 11. North America Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 12. North America Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 13. North America Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 14. North America Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 15. North America Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 16. North America Multiplex Assays Market Share (%), By Country, 2017-2031F
Figure 17. United States Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 18. United States Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 19. United States Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 20. United States Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 21. United States Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 22. United States Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 23. United States Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 24. Canada Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 25. Canada Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 26. Canada Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 27. Canada Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 28. Canada Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 29. Canada Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 30. Canada Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 31. Mexico Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 32. Mexico Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 33. Mexico Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 34. Mexico Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 35. Mexico Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 36. Mexico Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 37. Mexico Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 38. Europe Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 39. Europe Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 40. Europe Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 41. Europe Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 42. Europe Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 43. Europe Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 44. Europe Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 45. Europe Multiplex Assays Market Share (%), By Country, 2017-2031F
Figure 46. Germany Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 47. Germany Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 48. Germany Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 49. Germany Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 50. Germany Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 51. Germany Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 52. Germany Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 53. France Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 54. France Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 55. France Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 56. France Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 57. France Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 58. France Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 59. France Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 60. Italy Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 61. Italy Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 62. Italy Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 63. Italy Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 64. Italy Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 65. Italy Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 66. Italy Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 67. United Kingdom Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 68. United Kingdom Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 69. United Kingdom Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 70. United Kingdom Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 71. United Kingdom Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 72. United Kingdom Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 73. United Kingdom Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 74. Russia Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 75. Russia Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 76. Russia Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 77. Russia Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 78. Russia Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 79. Russia Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 80. Russia Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 81. Netherlands Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 82. Netherlands Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 83. Netherlands Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 84. Netherlands Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 85. Netherlands Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 86. Netherlands Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 87. Netherlands Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 88. Spain Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 89. Spain Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 90. Spain Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 91. Spain Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 92. Spain Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 93. Spain Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 94. Spain Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 95. Turkey Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 96. Turkey Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 97. Turkey Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 98. Turkey Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 99. Turkey Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 100. Turkey Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 101. Turkey Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 102. Poland Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 103. Poland Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 104. Poland Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 105. Poland Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 106. Poland Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 107. Poland Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 108. Poland Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 109. South America Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 110. South America Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 111. South America Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 112. South America Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 113. South America Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 114. South America Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 115. South America Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 116. South America Multiplex Assays Market Share (%), By Country, 2017-2031F
Figure 117. Brazil Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 118. Brazil Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 119. Brazil Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 120. Brazil Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 121. Brazil Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 122. Brazil Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 123. Brazil Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 124. Argentina Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 125. Argentina Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 126. Argentina Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 127. Argentina Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 128. Argentina Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 129. Argentina Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 130. Argentina Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 131. Asia-Pacific Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 132. Asia-Pacific Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 133. Asia-Pacific Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 134. Asia-Pacific Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 135. Asia-Pacific Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 136. Asia-Pacific Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 137. Asia- Pacific Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 138. Asia-Pacific Multiplex Assays Market Share (%), By Country, 2017-2031F
Figure 139. India Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 140. India Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 141. India Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 142. India Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 143. India Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 144. India Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 145. India Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 146. China Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 147. China Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 148. China Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 149. China Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 150. China Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 151. China Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 152. China Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 153. Japan Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 154. Japan Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 155. Japan Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 156. Japan Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 157. Japan Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 158. Japan Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 159. Japan Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 160. Australia Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 161. Australia Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 162. Australia Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 163. Australia Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 164. Australia Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 165. Australia Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 166. Australia Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 167. Vietnam Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 168. Vietnam Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 169. Vietnam Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 170. Vietnam Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 171. Vietnam Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 172. Vietnam Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 173. Vietnam Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 174. South Korea Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 175. South Korea Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 176. South Korea Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 177. South Korea Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 178. South Korea Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 179. South Korea Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 180. South Korea Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 181. Indonesia Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 182. Indonesia Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 183. Indonesia Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 184. Indonesia Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 185. Indonesia Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 186. Indonesia Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 187. Indonesia Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 188. Philippines Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 189. Philippines Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 190. Philippines Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 191. Philippines Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 192. Philippines Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 193. Philippines Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 194. Philippines Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 195. Middle East & Africa Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 196. Middle East & Africa Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 197. Middle East & Africa Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 198. Middle East & Africa Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 199. Middle East & Africa Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 200. Middle East & Africa Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 201. Middle East & Africa Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 202. Middle East & Africa Multiplex Assays Market Share (%), By Country, 2017-2031F
Figure 203. Saudi Arabia Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 204. Saudi Arabia Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 205. Saudi Arabia Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 206. Saudi Arabia Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 207. Saudi Arabia Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 208. Saudi Arabia Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 209. Saudi Arabia Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 210. UAE Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 211. UAE Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 212. UAE Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 213. UAE Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 214. UAE Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 215. UAE Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 216. UAE Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 217. South Africa Multiplex Assays Market, By Value, In USD Billion, 2017-2031F
Figure 218. South Africa Multiplex Assays Market, By Volume, In Million Units, 2017-2031F
Figure 219. South Africa Multiplex Assays Market Share (%), By Product, 2017-2031F
Figure 220. South Africa Multiplex Assays Market Share (%), By Type, 2017-2031F
Figure 221. South Africa Multiplex Assays Market Share (%), By Technology, 2017-2031F
Figure 222. South Africa Multiplex Assays Market Share (%), By Application, 2017-2031F
Figure 223. South Africa Multiplex Assays Market Share (%), By End-user, 2017-2031F
Figure 224. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 225. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 226. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 227. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 228. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11642

Global multiplex assays market is projected to witness a CAGR of 10.16% during the forecast period 2024-2031, growing from USD 3.19 billion in 2023 to USD 6.92 billion in 2031. The market's expansion is boosted by the increasing prevalence of autoimmune, chronic, and infectious diseases, rising investments towards drug development and discovery, and growing applications of multiplex assays. Detection of autoantibodies is essential in cancer, autoimmune, cytokine, and infectious disease research and multiplex analysis aids researchers in measuring several autoantibodies from one sample, increasing time efficiency. Thus, propelling the requirement for multiplex assays for clinical and life science applications.

The increasing cases of cancer in various regions across the globe are propelling the global multiplex assays market demand. As per the estimates of the National Cancer Institute, 2,001,140 new cases of cancer are expected to be diagnosed in the United States in 2024. Circulating cancer biomarker bead-based multiplex assays that use Luminex technology allow the simultaneous analysis of multiple oncology biomarkers in several types of tumors. They are also aiding in supporting advancements in immune-oncology, lung cancer, and breast cancer research. Detecting isolated protein biomarkers is not often sufficient for distinguishing non-tumor from tumor, the deployment of multiplexed detection of circulating and intracellular cancer markers with the help of multiplex assays can boost the acceleration of studies related to tumorigenic processes and normal homeostasis.

Rising Autoimmune Cases Boost Market Demand

The rising cases of autoimmune diseases are positively influencing the growth of the market as multiplex autoantibody assays are capable of detecting several autoantibodies that are present in a wide range of patients with systemic autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus, in one run. According to estimates from the Johns Hopkins Medicine, autoimmune diseases affect approximately 3% of the population of the United States. The correct interpretation and usage of serological testing for providing a diagnosis of autoimmune disease presents various challenges because of the specificity and sensitivity of tests that are used for detecting autoimmune diseases and the provision of different results by techniques such as MBAA and indirect immunofluorescence that are used for detecting autoantibodies. Multiplex immunoassays also provide a wide range of advantages, including the ability to deliver more information from the sample in a time-efficient manner.

Increasing Investments in Drug Development Boost Market Growth

The rising emphasis towards drug development and discovery is one of the major factors boosting the global multiplex assays market size. Drug discovery aids the pharmaceutical sector in determining the molecular entities that can be beneficial in treating diseases. The various steps associated with the drug development process aid in assessing the safety, efficacy, and the various risks associated with the drugs. Thus, various companies actively invest in the development of solutions that are capable of increasing the speed of the different steps essential in drug development and discovery. For instance, in March 2024, Semarion Ltd, a spin-out company of the University of Cambridge, introduced their SemaCyte Multiplexing Platform that is designed for augmenting the speed and quality of data generation. The multiplexing platform was developed with the help of the company's microarray technology and is designed to provide flexibility and resource efficiency and a more systemized route for conducting cell assays.

North America Accounts for Significant Market Share

The growth of the market in North America is supported by the rising cases of chronic and infectious diseases in the region, increasing investments by healthcare and biotechnology companies towards the development of advanced technologies, a high rate of acceptance of novel technological solutions, and rapid expansion of the healthcare sector. Furthermore, the strong presence of biotechnology companies in the region, coupled with increasing investments to promote the development of novel solutions, is also supporting the market's expansion in North America. For instance, in June 2024, RareCyte, Inc., one of the leading life science companies, announced the completion of funding of USD 20 million from existing and new investors. This funding is expected to support the company in boosting the expansion of the Orion Spatial Biology platform, which includes commercializing software applications, multiplex assays, and reagent products.

Protein Multiplex Assays Expected to Witness Significant Growth

The segment's expansion is supported by the increasing investments and emphasis on proteomics studies for clinical diagnosis and biomarker research. In October 2023, Thermo Fisher Scientific Inc. acquired Olink for USD 3.1 billion to expand its presence in the proteomics sector. The latter provides a platform of products and services that are proteomics-focused; their proximity extension assay (PEA) technology has been designed to enable high throughput. Such acquisitions underscore the impact that the field of proteomics has had on advancements in precision medicine and life science research, among others. The rising investments towards the research and development activities by various pharmaceutical companies and research institutions towards protein multiplex assays also bolster the growth of the segment. These assays also provide a wide range of advantages regarding the sample requirements and the amount of data generated, along with time and cost efficiency.

Future Market Scenario (2024-2031F)

According to the global multiplex assays market analysis, the rising cancer cases are expected to provide lucrative growth opportunities to the market. The American Cancer Society estimates that the number of cases of cancer will reach 35 million by 2050. This rise is anticipated to propel the market demand as it aids in enhancing the understanding of the role of various immune regulators in cancer and quantitative profiling of co-stimulating and co-inhibitory immune checkpoint proteins. Additionally, the rising cases of infectious diseases are also supporting the expansion of the market as multiplex testing supports the detection of multiple loci or analytes from several pathogens in a single well. Furthermore, the growth of the market is also supported by the rising research and development activities by various biotechnology companies and research institutions across the globe. For instance, the Oslo University Hospital is conducting an interventional study that is expected to conclude in December 2025 to assess the clinical utility of circulating tumor DNA assays in patients that have advanced malignancies. The project aims to evaluate the extent to which the circulating tumor DNA assays are relevant in clinical decision-making.

Key Players Landscape and Outlook

The increasing efforts of the key players of the market towards the development of advanced solutions is one of the major factors bolstering the global multiplex assays market growth. In April 2024, Bio-Rad Laboratories, Inc. announced the launch of the ddPLEX ESR1 mutation detection kit, an ultrasensitive multiplexed digital PCR assay that enables quantification, discrimination, and detection of seven ESR1 mutations and allows customers to achieve multiplexing and sensitivity, without compromising throughput. Such developments showcase the dedication of the key market players to provide new technologies to cancer researchers that will enable everything that boosts improvement in patient monitoring.

The growth of the market is also supported by the increasing introduction of novel products and technologies by the key players in the market in various geographical locations. In February 2023, Thermo Fisher Scientific Inc. launched PCR kits for detecting infectious diseases in India. The Applied Biosystems TaqPath PCR kits have been clinically and analytically validated for use in diagnosis and disease screening, identification of risk factors that are genetic, and monitoring of disease progression and therapeutic responses in patients. Such efforts showcase the dedication of the company for providing new workflows and innovation to enhance diagnostic solutions and advance research of infectious diseases.

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Multiplex Assays Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. By Product
- 4.2.1. Instruments and Accessories
- 4.2.2. Reagents and Consumables
- 4.2.3. Software and Services
4.3. By Type
- 4.3.1. Nucleic Acid Multiplex Assays
  - 4.3.1.1. Planar Nucleic Acid Assays
  - 4.3.1.2. Bead-based Nucleic Acid Multiplex Assays
  - 4.3.1.3. Others
- 4.3.2. Protein Multiplex Assays
  - 4.3.2.1. Planar Protein Assays
  - 4.3.2.2. Bead-based Protein Assays
  - 4.3.2.3. Others
- 4.3.3. Cell-based Multiplex Assays
4.4. By Technology
- 4.4.1. Protein Microarray
- 4.4.2. Polymerase Chain Reaction
- 4.4.3. Fluorescence Detection
- 4.4.4. Flow Cytometry
- 4.4.5. Multiplex Real-Time PCR
- 4.4.6. Luminescence
- 4.4.7. Others
4.5. By Application
- 4.5.1. Clinical Diagnostics
  - 4.5.1.1. Cancer
  - 4.5.1.2. Infectious Diseases
  - 4.5.1.3. Autoimmune Diseases
  - 4.5.1.4. Metabolism and Endocrinology Disorders
  - 4.5.1.5. Nervous System Disorders
  - 4.5.1.6. Cardiovascular Diseases
  - 4.5.1.7. Others
- 4.5.2. Research and Development
  - 4.5.2.1. Biomarker Discovery and Validation
  - 4.5.2.2. Drug Discovery and Development
4.6. By End-user
- 4.6.1. Pharmaceutical and Biotechnology Companies
- 4.6.2. Hospitals
- 4.6.3. Academic and Research Institutes
- 4.6.4. Clinical Laboratories
- 4.6.5. Others
4.7. By Region
- 4.7.1. North America
- 4.7.2. South America
- 4.7.3. Europe
- 4.7.4. Asia-Pacific
- 4.7.5. Middle East and Africa
4.8. By Company Market Share (%), 2023

5. Global Multiplex Assays Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. By Value
  - 5.1.1.2. By Volume
- 5.1.2. By Product
  - 5.1.2.1. Instruments and Accessories
  - 5.1.2.2. Reagents and Consumables
  - 5.1.2.3. Software and Services
- 5.1.3. By Type
  - 5.1.3.1. Nucleic Acid Multiplex Assays
    - 5.1.3.1.1. Planar Nucleic Acid Assays
    - 5.1.3.1.2. Bead-based Nucleic Acid Multiplex Assays
    - 5.1.3.1.3. Others
  - 5.1.3.2. Protein Multiplex Assays
    - 5.1.3.2.1. Planar Protein Assays
    - 5.1.3.2.2. Bead-based Protein Assays
    - 5.1.3.2.3. Others
  - 5.1.3.3. Cell-based Multiplex Assays
- 5.1.4. By Technology
  - 5.1.4.1. Protein Microarray
  - 5.1.4.2. Polymerase Chain Reaction
  - 5.1.4.3. Fluorescence Detection
  - 5.1.4.4. Flow Cytometry
  - 5.1.4.5. Multiplex Real-Time PCR
  - 5.1.4.6. Luminescence
  - 5.1.4.7. Others
- 5.1.5. By Application
  - 5.1.5.1. Clinical Diagnostics
    - 5.1.5.1.1. Cancer
    - 5.1.5.1.2. Infectious Diseases
    - 5.1.5.1.3. Autoimmune Diseases
    - 5.1.5.1.4. Metabolism and Endocrinology Disorders
    - 5.1.5.1.5. Nervous System Disorders
    - 5.1.5.1.6. Cardiovascular Diseases
    - 5.1.5.1.7. Others
  - 5.1.5.2. Research and Development
    - 5.1.5.2.1. Biomarker Discovery and Validation
    - 5.1.5.2.2. Drug Discovery and Development
- 5.1.6. By End-user
  - 5.1.6.1. Pharmaceutical and Biotechnology Companies
  - 5.1.6.2. Hospitals
  - 5.1.6.3. Academic and Research Institutes
  - 5.1.6.4. Clinical Laboratories
  - 5.1.6.5. Others
- 5.1.7. United States*
  - 5.1.7.1. Market Size & Forecast
    - 5.1.7.1.1. By Value
    - 5.1.7.1.2. By Volume
  - 5.1.7.2. By Product
    - 5.1.7.2.1. Instruments and Accessories
    - 5.1.7.2.2. Reagents and Consumables
    - 5.1.7.2.3. Software and Services
  - 5.1.7.3. By Type
    - 5.1.7.3.1. Nucleic Acid Multiplex Assays
      - 5.1.7.3.1.1. Planar Nucleic Acid Assays
      - 5.1.7.3.1.2. Bead-based Nucleic Acid Multiplex Assays
      - 5.1.7.3.1.3. Others
    - 5.1.7.3.2. Protein Multiplex Assays
      - 5.1.7.3.2.1. Planar Protein Assays
      - 5.1.7.3.2.2. Bead-based Protein Assays
      - 5.1.7.3.2.3. Others
    - 5.1.7.3.3. Cell-based Multiplex Assays
  - 5.1.7.4. By Technology
    - 5.1.7.4.1. Protein Microarray
    - 5.1.7.4.2. Polymerase Chain Reaction
    - 5.1.7.4.3. Fluorescence Detection
    - 5.1.7.4.4. Flow Cytometry
    - 5.1.7.4.5. Multiplex Real-Time PCR
    - 5.1.7.4.6. Luminescence
    - 5.1.7.4.7. Others
  - 5.1.7.5. By Application
    - 5.1.7.5.1. Clinical Diagnostics
      - 5.1.7.5.1.1. Cancer
      - 5.1.7.5.1.2. Infectious Diseases
      - 5.1.7.5.1.3. Autoimmune Diseases
      - 5.1.7.5.1.4. Metabolism and Endocrinology Disorders
      - 5.1.7.5.1.5. Nervous System Disorders
      - 5.1.7.5.1.6. Cardiovascular Diseases
      - 5.1.7.5.1.7. Others
    - 5.1.7.5.2. Research and Development
      - 5.1.7.5.2.1. Biomarker Discovery and Validation
      - 5.1.7.5.2.2. Drug Discovery and Development
  - 5.1.7.6. By End-user
    - 5.1.7.6.1. Pharmaceutical and Biotechnology Companies
    - 5.1.7.6.2. Hospitals
    - 5.1.7.6.3. Academic and Research Institutes
    - 5.1.7.6.4. Clinical Laboratories
    - 5.1.7.6.5. Others
- 5.1.8. Canada
- 5.1.9. Mexico

All segments will be provided for all regions and countries covered

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. Asia-Pacific
- 5.3.1. India
- 5.3.2. China
- 5.3.3. Japan
- 5.3.4. Australia
- 5.3.5. Vietnam
- 5.3.6. South Korea
- 5.3.7. Indonesia
- 5.3.8. Philippines
5.4. South America
- 5.4.1. Brazil
- 5.4.2. Argentina
5.5. Middle East and Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Product
6.2. By Type
6.3. By Technology
6.4. By Application
6.5. By End-user
6.6. By Region

7. Macro Environment and Industry Structure

7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat From New Entrants
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Thermo Fisher Scientific Inc.
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products and Services
- 13.1.4. Financials (As Reported)
- 13.1.5. Key Market Focus and Geographical Presence
- 13.1.6. Recent Developments
13.2. Illumina, Inc.
13.3. Bio-Rad Laboratories, Inc.
13.4. QIAGEN N.V.
13.5. Becton, Dickinson and Company
13.6. DiaSorin S.p.A.
13.7. Seegene, Inc.
13.8. Abcam Limited
13.9. MESO SCALE DIAGNOSTICS, LLC
13.10. Merck KGaA

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

マルチプレックスアッセイの世界市場の評価：製品別、タイプ別、技術別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Multiplex Assays Market Assessment, By Product, By Type, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界のマルチプレックスアッセイ市場の見通し、2017年～2031年

第5章世界のマルチプレックスアッセイ市場の見通し（地域別、2017年～2031年）

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要参入企業の見通し

第14章戦略的提言

第15章お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Multiplex Assays Market Outlook, 2017-2031F

5. Global Multiplex Assays Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

マルチプレックスアッセイの世界市場の評価：製品別、タイプ別、技術別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Multiplex Assays Market Assessment, By Product, By Type, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界のマルチプレックスアッセイ市場の見通し、2017年～2031年

第5章 世界のマルチプレックスアッセイ市場の見通し（地域別、2017年～2031年）

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要参入企業の見通し

第14章 戦略的提言

第15章 お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Multiplex Assays Market Outlook, 2017-2031F

5. Global Multiplex Assays Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界のマルチプレックスアッセイ市場の見通し、2017年～2031年

第5章世界のマルチプレックスアッセイ市場の見通し（地域別、2017年～2031年）

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要参入企業の見通し

第14章戦略的提言

第15章お問い合わせと免責事項